OAC Newsroom

Obesity Action Coalition Calls on Starbucks to Reverse Decision to End GLP-1 Coverage for Obesity
in 2026 News Releases, News Releases on August 21, 2026

FOR IMMEDIATE RELEASE: August 21, 2026                                               Obesity Action Coalition Calls on Starbucks to Reverse Decision to End GLP-1 Coverage for Obesity Tampa, FL —The Obesity Action Coalition (OAC) is calling on Starbucks to reverse its reported decision to end health plan coverage of GLP-1 medications prescribed for weight loss beginning in October. Business Insider
Read Article

Obesity Action Coalition Extends Early Bird Pricing for the Your Weight Matters National Convention Through June 22
in 2026 News Releases on May 22, 2026

FOR IMMEDIATE RELEASE: May 22, 2026 Obesity Action Coalition Extends Early Bird Pricing for the Your Weight Matters National Convention Through June 22 Tampa, FL — The Obesity Action Coalition (OAC) announced today that they are extending Early Bird registration pricing for the 2026 Your Weight Matters National Convention through June 22, giving attendees additional
Read Article

Obesity Action Coalition Calls on Southwest Airlines to Standardize Customer of Size Policy Following Reports of Passenger Mistreatment
in 2026 News Releases on April 16, 2026

FOR IMMEDIATE RELEASE: April 16, 2026                 Obesity Action Coalition Calls on Southwest Airlines to Standardize Customer of Size Policy Following Reports of Passenger Mistreatment Tampa, FL — The Obesity Action Coalition (OAC) is calling on Southwest Airlines to immediately establish clear, consistent and respectful standards for its
Read Article

Obesity Care Week 2026 Concludes with Global Momentum for Advancing Care
in 2026 News Releases, News Releases on March 6, 2026

FOR IMMEDIATE RELEASE: March 6, 2026   Tampa, FL — As Obesity Care Week (OCW) 2026 comes to a close, organizers and supporters are reflecting on a week dedicated to advancing understanding, challenging stigma and promoting meaningful action. This year’s theme, “Commit to Care,” encouraged individuals and organizations around the world to elevate conversations about obesity
Read Article

Obesity Action Coalition and American Heart Association Announce Collaboration to Support Healthy Living BEYOND Weight™ Study
in 2026 News Releases, News Releases on January 15, 2026

FOR IMMEDIATE RELEASE January 15, 2026 Obesity Action Coalition and the American Heart Association Announce Collaboration to Support Healthy Living BEYOND Weight Study Tampa, FL — The Obesity Action Coalition (OAC) today announced a new collaboration with the American Heart Association to support recruitment and engagement for the Association’s Healthy Living BEYOND Weight™ Study, which is
Read Article

OAC Marks 20 Years of Impact and Looks ahead to the Work Still to Come
in 2025 News Releases, News Releases on December 3, 2025

Tampa, FL — As the Obesity Action Coalition (OAC) closes its 20th anniversary year, the organization celebrates two decades of empowering individuals affected by obesity through education, advocacy, awareness and community support. “Celebrating 20 years is incredible, but what really drives me is the people whose lives we’ve touched,” said Joe Nadglowski, OAC President and
Read Article

OAC Statement on GLP-1 Medications as a Long-Term Treatment Strategy for Obesity
in 2025 News Releases, News Releases on December 1, 2025

Tampa, FL., December 1, 2025 – Statement from Obesity Action Coalition (OAC) President and CEO Joe Nadglowski: “The World Health Organization’s new recommendation for GLP-1 medications as part of a long-term treatment strategy for obesity is a significant milestone in recognizing obesity as a chronic, treatable disease. These medications, which can help reduce weight and
Read Article

Obesity Action Coalition (OAC) Applauds the Administration’s Plan to Expand Access to Obesity Medications
in 2025 News Releases on November 6, 2025

Tampa, FL — The Obesity Action Coalition (OAC) welcomes today’s announcement from the White House outlining new agreements with pharmaceutical manufacturers to significantly lower the cost of several FDA-approved medications, including those used to treat obesity. Under the new agreements, Medicare beneficiaries will pay a co-pay of just $50 per month, making these life-changing treatments
Read Article